Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Intan Baru Prana Tbk. (IBFN) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Intan Baru Prana Tbk.Trade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Intan Baru Prana Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Intan Baru Prana Tbk. trades at Rp63 (market cap 103.18B, 799.4K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume). The key difference: Brigit Biofarmaka Teknologi Tbk. is the larger of the two by market cap, and Intan Baru Prana Tbk. is more actively traded (799.4K versus 324K). Which is the better fit depends on your goals.

IBFNOBAT
Market Cap
103.18B166.01B
Volume
799.4K324K
Lot
7.99K3.24K
Turnover
77.68M
Average Price
239.75
Value
77.68M
Indicative Equilibrium Price
240
Indicative Equilibrium Volume
1

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

IBFN
View details
OBAT
View details

About Intan Baru Prana Tbk.

PT Intan Baruprana Finance Tbk (the Company) was established based on Notarial Deed No. 19 dated September 4, 1991 and amended by Notarial Deed No. 121 dated June 16, 1993 of Esther Daniar Iskandar, S.H., notary in Jakarta. The Company started its commercial operations in 1997. The Company is part of the Intraco Penta group of companies.

Read more on IBFN

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT